Board of trustees
KGI Trustees are visionary leaders in business, industry, and education. The Board of Trustees, in conjunction with other advisory boards at KGI, needs to keep the Institute ever mindful of current features in the life sciences industry.
Trustees bear ultimate responsibility for directing the conduct of KGI's activities and affairs and for overseeing its operations, including:
- Approval of the Institute's strategic plan, mission, and goals;
- Approval of the Institute's annual operating plans, budget, and financial performance;
- Oversight of the Institute's annual audit;
- Advisement on significant Institutional and academic issues, actions, transactions, and legal matters;
- Nominations of trustees and assurance of effective governance;
- Selection of the president and plans for succession;
- Oversight of evaluations and compensation for the president and senior staff.
Madhavan (Madhu) Balachandran
Executive Vice President, Operations, Amgen
Co-founder and Chairman, BioCentury Publications
Frank J. Biondi, Jr.
Senior Managing Director, WaterView Advisors
Daniel M. Bradbury
Managing Member, BioBrit, LLC
Robert E. Curry, Chairman of the Board
Partner, Latterell Venture Partners
Chief Medical Officer, Unity Pharmaceuticals
Joann P. DiGennaro
President, Center for Excellence in Education
Stephen L. Eck
Vice President, Global Head of Medical Oncology Sciences, Astellas Pharma Global Development
Dennis M. Fenton
Fenton & Associates LLC; Former Executive Vice President, Amgen
Ross A. Grossman
Former Senior Vice President, Human Resources, Regeneron Pharmaceuticals, Inc.
Gregg A. Lapointe
CEO, Cerium Pharmaceuticals
Rodney S. Markin
Associate Vice Chancellor for Business Development and Chief Technology Officer, University of Nebraska Medical Center
Barbara J. Mazur
Vice President, Technology Acquisition Strategy, DuPont Pioneer
Yolanda T. Moses
Professor of Anthropology and Associate Vice Chancellor for Diversity, Equity and Excellence, University of California, Riverside
Jeereddi A. Prasad
President, ProMed Health Care Administrators
Arthur D. Riggs
Director Emeritus & Chair, Diabetes Research Department, Beckman Research Institute, City of Hope
José Ignacio Santos
Professor, Experimental Medicine Unit, School of Medicine, National Autonomous University of Mexico
Former General Manager of Technology Partnerships, Honeywell, Inc.
Sheldon M. Schuster
President, Keck Graduate Institute
Regan G. Shea
Senior Vice President of Chemical and Biologics Operations, Gilead Sciences
Alexander B. Suh
Founding Managing Director, California Technology Ventures, LLC
Chairman Emeritus, MWH Global, Inc.
Board Member and Former CEO and CSO of Cytonome/ST, LLC
James F. Widergren
CEO and President, ORGENTEC and Corgenix
Lilian S. Wu
Program Executive, IBM Global University Programs
President and CEO, Veracyte, Inc.
John D. Baldeschwieler
Professor Emeritus, California Institute of Technology
Human Resources Consultant; Former Senior Vice President of Human Resources, Genentech Inc.
Alice S. Huang
Senior Faculty Associate in Biology and Biological Engineering, California Institute of Technology
Howard B. Keck, Jr.
President, Brighton Distributing Company
John D. Leland, Jr.
Retired, Founding Partner, RCM Capital Management
Richard L. McConnell
Former President, Pioneer DuPont
Bernard E. Kury
Former Vice President and General Counsel, Guidant Corporation
Clifford A. Miller
Chairman, The Clifford Group, Inc.
Stanford N. Phelps
Chairman, S. N. Phelps & Co.
William H. Rastetter
Chairman, Board of Directors, Illumina Inc.
Louis T. Rosso
Chairman Emeritus, Beckman Coulter Inc.
Jack L. Stark
President Emeritus, Claremont McKenna College
Robert E. Tranquada
Emeritus Professor of Medicine & Public Policy, University of Southern California
Partner, Capital World Investors